维普期刊资源整合服务平台（V6.5）

123篇 您的检索式：作者名="Van Cutsem P"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic coloreetal cancer? A report from the european colorectal metastases treatment group 显示文摘	Nordlinger B Van Cutsem E Rougier P	2007	Eur J Cancer2007，43，14：	1
2	Definition and classification of power system stability 显示文摘	KUNDUR P PASERBA J AJJARAPU V ANDERSSON G BOSE A CANIZARES C HATZIARGYRIOU N HILL D STANKOVICA TAYLOR C van CUTSEM T VITTAL V	2004	IEEE Transactions on Power Systems2004，19，3：	1
3	Oral Capecitabine vs intravenous 5 -fluorouracil and leueovorin: integrated efficacy data and novel analyses from two large, randomised phase III trials显示文摘	Van Cutsem EV Hoff PM Harper P	2004	Br J Cancer2004，90，6：	1
4	Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone显示文摘	van Cutsem E Rutgeerts P Vantrappen G		Lancet0，，：	1
5	Cloning and sequencing of the 1-SST cDNA from chicory root 显示文摘	De Halleux S Van Cutsem P	1997	Plant Physiology1997，113，：	1
6	Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma显示文摘	Flamen P Lerut A Van Cutsem E	2000	J Clin Oncol2000，18，18：	1
7	Utility of 18F-FDG positon emission tomagraphy for the staging of patients with potentially oprable esophageal carcinoma 显示文摘	Flamen P Leurt A van Cutsem E	2000	J Clin Oncol2000，18，：	1
8	Oral eapecitabinevs intravenous 5-fluorouracil and leueovorin : integrated efficacy data and novel analyses from two large, randomized, phase Ⅲ trials显示文摘	Van Cutsem E Hoff PM Harper P	2004	Br J Cancer2004，90，6：	1
9	Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer 显示文摘	Rougier P Van Cutsem E Bajetta E	1998	Lancet1998，352，9138：	1
10	Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma显示文摘	Lerut A Van Cutsem E etal	2000	J Clin Oncol2000，18，18：	1
11	Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone显示文摘	van Cutsem E Rutgeerts P Vantrappen G	1990	Lancet1990，335，8695：	1
12	Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer显示文摘	van de VELDE H KARASEK P	2004	J Clin Oncol2004，22，8：	1
13	Phase Ⅲ trial of gemeitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer显示文摘	Van Cutsem E van de Velds H Karasek P	2004	J Clin Oncol2004，22，：	1
14	Whole-body PET with FDG for the diagnosis of recurrent gastric cancer 显示文摘	De Potter T Flamen P Van Cutsem E	2002	Eur J Nucl Med Mol Imaging2002，29，4：	1
15	Pharse Ⅲtrial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer 显示文摘	Van de velde P Karasek H	2004	J Clin Oncol2004，，：	1
16	PET for assessment of the response to induction chemotherapy in locally advanced esophagel cancer显示文摘	Flamen P Van Cutsem E Lerut A	2002	Ann Oncol2002，13，3：	1
17	Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer:pooled analysis of the CRYSTAL and OPUS randomised clinical trials显示文摘	Bokemeyer C Van Cutsem E Rougier P	2012	Eur J Cancer2012，48，10：	1
18	Oral capoeitabin vesus intravenous 5-flumrouracil and leueovorin:integrated efficacy dataand novel analyses from two large,randomized,phaseⅢtrims显示文摘	van Cutsem E Hoff P Harper P	2004	Br J cancer2004，，90：	1
19	Wholebody PET with FDG for the diagnosis of recurrent gastric cancer显示文摘	De Potter T Flamen P Van Cutsem E	2002	Eur J Nucl Med Mol Imaging2002，29，4：	1
20	Whole Body PET with FDG for the Diagnosis of Recurrent Gastric Cancer显示文摘	De Potter T Flamen P Van Cutsem E	2002	J Nucl Med Mol Imaging2002，29，4：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示